Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.17M | -32.79M | -25.83M | -52.05M | -21.51M |
| Total Depreciation and Amortization | 1.98M | 2.37M | 2.03M | 1.84M | 1.89M |
| Total Amortization of Deferred Charges | 469.00K | 468.00K | 469.00K | 369.00K | 170.00K |
| Total Other Non-Cash Items | 11.23M | 10.89M | 3.04M | 29.61M | 1.81M |
| Change in Net Operating Assets | 2.12M | 711.00K | -5.98M | -3.46M | -360.00K |
| Cash from Operations | -18.37M | -18.34M | -26.27M | -23.70M | -18.00M |
| Capital Expenditure | -9.99M | -7.50M | -8.27M | -8.04M | -4.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.93M | 80.00K | 37.00K | 283.00K | 43.00K |
| Cash from Investing | -14.92M | -7.42M | -8.23M | -7.76M | -4.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 149.29M | -- | -- | 218.16M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.00K | -27.00K | -1.88M | -3.46M | -119.00K |
| Cash from Financing | 149.18M | -27.00K | -1.88M | 214.70M | -119.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.90M | -25.79M | -36.38M | 183.24M | -22.57M |